Sonova Holding, providers of hearing aid solutions, has completed the placement of CHF 450 million Bonds governed by Swiss law. Application will be made for the Bonds to be listed on the SIX Swiss Exchange. The
Tags :Homburger
CDR-Life, a Swiss biotechnology company pioneering a new and differentiated class of highly tumor-specific immune-oncology therapeutics, has completed its Series A financing raising USD 76 million. The round was led by Jeito Capital and RA Capital
SonarSource, a platform for clean code, has completed a growth equity financing by General Catalyst, Advent International, Insight Partners, and Permira’s Growth Opportunities Fund. The financing raised USD 412 million in new investment
Zürcher Kantonalbank has completed its issuance of EUR 500 million 2.020 per cent. Fixed-to-Floating Rate Tier 2 Bonds due 2028. The Bonds are regulatory capital instruments that are eligible to fulfill Zürcher Kantonalbank’s Swiss gone concern
Aris Gold Corporation has entered into a definitive agreement with MDC Industry Holding Company, a wholly owned subsidiary of the Abu Dhabi based investment company Mubadala Investment Company, whereby Aris Gold would acquire a 20% joint
On April 7, 2022, Credit Suisse completed its registered offering of USD 2.5 billion aggregate principal amount of senior notes. The offering consisted of USD 2.1 billion aggregate principal amount of 3.700% senior notes due 2025 and USD 400 million aggregate principal
Bcomp, lightweighting specialists, closed its oversubscribed Series B financing round of CHF 32.4 million (USD 35 m). The round was led by automotive OEM venture funds BMW i Ventures and included a group of mobility
Ginkgo Bioworks, a horizontal platform for cell programming, entered into a definitive purchase agreement to acquire FGen, a Swiss company specializing in strain development and optimization. Ginkgo Bioworks believes that FGen’s technology will significantly
VectivBio, a clinical-stage biotechnology company developing transformational medicines for patients with serious rare diseases, has entered into a loan agreement with Kreos Capital, a global growth lender to life sciences and healthcare companies, granting VectivBio
Francotyp-Postalia, a stock-listed international active group of companies which provides digital business solutions, mailing, shipping & office solutions and mail services, has acquired all shares in the operating companies of Azolver Group. Azolver Group focuses
